The University of Chicago Header Logo

Connection

Peter Riedell to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Peter Riedell has written about Drug Resistance, Neoplasm.
Peter Riedell
Connection Strength
0.041
Drug Resistance, Neoplasm
  1. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. N Engl J Med. 2022 02 17; 386(7):640-654.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.